Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Lusupultide

EU orphan designation number: EU/3/07/457
Active ingredient: Lusupultide
Indication: Treatment of aspiration pneumonitis requiring intubation and mechanical ventilation
Sponsor: Nycomed GmbH
Byk-Gulden-Straße 2, D-78467 Konstanz, Deutschland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/07/2007 Centralised Orphan - Designation EMEA/OD/009/06 (2007)3429 of 10/07/2007
24/10/2007 Centralised Orphan - Transfer of orphan designation EMEA/OD/009/07/T/01 (2007)4379 of 17/09/2007
16/02/2009 Centralised Orphan - Removal of orphan designation from Community Register